AB
MDGL icon

Amalgamated Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History

Amalgamated Bank’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$688K Buy
1,281
+751
+142% +$385K ﹤0.01% 1268
2026
Q1 		$277K Sell
530
-54
-9% -$25.8K ﹤0.01% 1487
2025
Q4 		$340K Sell
584
-19
-3% -$9.7K ﹤0.01% 1445
2025
Q3 		$277K Sell
603
-19
-3% -$7.09K ﹤0.01% 1492
2025
Q2 		$188K Hold
622
– – ﹤0.01% 1565
2025
Q1 		$206K Buy
622
+15
+2% +$4.93K ﹤0.01% 1529
2024
Q4 		$187K Hold
607
– – ﹤0.01% 1593
2024
Q3 		$129K Hold
607
– – ﹤0.01% 1660
2024
Q2 		$170K Buy
607
+102
+20% +$24.3K ﹤0.01% 1618
2024
Q1 		$135K Sell
505
-1,614
-76% -$380K ﹤0.01% 1676
2023
Q4 		$490K Buy
2,119
+57
+3% +$9.97K ﹤0.01% 1456
2023
Q3 		$301K Buy
2,062
+29
+1% +$5.46K ﹤0.01% 1628
2023
Q2 		$470K Buy
2,033
+229
+13% +$62K ﹤0.01% 1469
2023
Q1 		$437K Sell
1,804
-292
-14% -$79.6K ﹤0.01% 1484
2022
Q4 		$608K Buy
2,096
+47
+2% +$4.6K 0.01% 1375
2022
Q3 		$133K Buy
2,049
+30
+1% +$2.08K ﹤0.01% 2014
2022
Q2 		$145K Buy
2,019
+100
+5% +$7.35K ﹤0.01% 2017
2022
Q1 		$188K Buy
+1,919
New +$162K ﹤0.01% 1965
2021
Q3 		– Sell
-2,145
Closed -$209K – 2174
2021
Q2 		$209K Buy
+2,145
New +$254K ﹤0.01% 2016
2018
Q3 		– Sell
-888
Closed -$248K – 1550
2018
Q2 		$248K Buy
+888
New +$156K 0.01% 1440

Other funds holding MDGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return

Amalgamated Bank's MDGL Position: Q2 2026 in Review

Amalgamated Bank increased its Madrigal Pharmaceuticals (MDGL) stake by 142% in Q2 2026, buying an estimated $385K and bringing the position to 1,281 shares worth $688K. The position accounts for ﹤0.01% of the portfolio, ranked #1268.

Amalgamated Bank first reported a position in MDGL in Q2 2018 and has held it in 20 quarters since. 181 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Amalgamated Bank held 1,281 shares of Madrigal Pharmaceuticals worth $688K as of Q2 2026.
  • Amalgamated Bank bought 751 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $385K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1268 holding.
  • Amalgamated Bank first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 20 quarters since.
  • 181 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.